News - Galapagos

Filter

Current filters:

Galapagos

Popular Filters

Argenta claims record year for peer-reviewed publications

09-12-2013

UK-based Argenta, a subsidiary of Belgian biotech firm Galapagos and a company that provides drug discovery…

ArgentaGalapagosPharmaceuticalResearch

Galapagos in deal with Biogen Idec for scleroderma research

Galapagos in deal with Biogen Idec for scleroderma research

13-11-2013

Belgian biotech firm Galapagos says that a subsidiary has signed a three-year collaboration agreement…

Biogen IdecBiotechnologyDermatologicalsGalapagosLicensingResearch

Galapagos touts superior potentiator series for cystic fibrosis

17-10-2013

Belgian biotech firm Galapagos has developed a series of novel potentiators in its cystic fibrosis program,…

BiotechnologyGalapagosRare diseasesResearch

Galapagos and Servier celebrate late stage discovery milestone

24-07-2013

Belgium-based Galapagos (Euronext: GLPG) has announced a late stage discovery milestone for small molecules…

Anti-Arthritics/RheumaticsBiotechnologyEuropeFinancialGalapagosPharmaceuticalServier

AbbVie to pay $50 million to expand GLPG0634 deal with Galapagos to Crohn's disease

17-05-2013

US drugmaker AbbVie (NYSE: ABBV) says it is extending its deal with Belgium-based Galapagos (Euronext:…

AbbVieAnti-Arthritics/RheumaticsGalapagosGLPG0634Inflammatory diseasesLicensingPharmaceuticalResearch

Roche pulls out of fibrosis alliance with Galapagos

11-03-2013

Belgium-based Galapagos (Euronext Brussels: GLPG) revealed that Swiss drug major Roche (ROG: SIX) has…

GalapagosLicensingPharmaceuticalRespiratory and PulmonaryRoche

Galapagos unit in CNS discovery deal with Ono Pharma

03-09-2012

Belgian biotech firm Galapagos NV (Euronext: GLPG) says that its service division BioFocus and Japanese…

BioFocusBiotechnologyGalapagosNeurologicalOno PharmaceuticalPharmaceuticalResearch

AstraZeneca in deal with Galapagos; view on Seroquel law suit

15-03-2012

BioFocus and Argenta, service companies of Netherlands-based Galapagos (Euronext: GLPG), yesterday announced…

Argenta DiscoveryAstraZenecaBioFocusGalapagosLegalNeurologicalPharmaceuticalResearchRespiratory and PulmonarySeroquelSeroquel XR

Galapagos leaps on $1.35 billion RA drug deal with Abbott Labs

01-03-2012

Belgian drug developer Galapagos (Euronext: GLPG) saw its shares rocket 27% to a record high 13.89 euros…

Abbott LaboratoriesAnti-Arthritics/RheumaticsBiotechnologyGalapagosLicensingPharmaceutical

GSK exercises option for Galapagos drug candidates

21-02-2012

Belgium-based Galapagos NV (Euronext: GLPG) says that its partner, UK pharma giant GlaxoSmithKline (LSE:…

Anti-Arthritics/RheumaticsBiotechnologyGalapagosGlaxoSmithKlineInflammatory diseasesLicensingPharmaceuticalResearch

Unexpectedly strong data for Galapagos rheumatoid arthritis drug candidate

24-11-2011

Shares of Belgium-based biotech firm Galapagos (Euronext: GLPG) jumped 22% on Tuesday and a further 12%…

Anti-Arthritics/RheumaticsAstraZenecaBiotechnologyfostamatinibGalapagosPfizerPharmaceuticalResearchtofacitinib

Servier and Galapagos in 260 million-euro oncology deal

04-10-2011

Leading independent French drugmaker Laboratoires Servier and Belgium’s Galapagos (Euronext: GLPG)…

GalapagosLicensingOncologyPharmaceuticalResearchServier

Galapagos units extend drug discovery collaboration with Genentech

19-08-2011

Galapagos units extend drug discovery collaboration with Genentech August 19, 2011 Belgium-based…

FinancialGalapagosGenentechPharmaceuticalResearchRoche

Company Spotlight

Fibrotech

Fibrotech

Back to top